Acacia Research (ACTG) Projected to Post Earnings on Wednesday

Acacia Research (NASDAQ:ACTG) is projected to issue its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect the company to announce earnings of ($0.14) per share and revenue of $38.00 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Wednesday, March 11, 2026 at 8:00 AM ET.

Acacia Research Stock Up 0.7%

Acacia Research stock opened at $4.11 on Tuesday. Acacia Research has a fifty-two week low of $2.70 and a fifty-two week high of $4.32. The firm has a market capitalization of $396.45 million, a price-to-earnings ratio of 82.22 and a beta of 0.52. The stock’s fifty day moving average is $3.96 and its two-hundred day moving average is $3.66. The company has a debt-to-equity ratio of 0.16, a quick ratio of 8.11 and a current ratio of 8.63.

Institutional Investors Weigh In On Acacia Research

A number of large investors have recently bought and sold shares of ACTG. AQR Capital Management LLC raised its holdings in shares of Acacia Research by 58.9% in the fourth quarter. AQR Capital Management LLC now owns 52,862 shares of the business services provider’s stock worth $198,000 after acquiring an additional 19,590 shares during the last quarter. Jane Street Group LLC purchased a new stake in shares of Acacia Research in the first quarter valued at $169,000. Wells Fargo & Company MN boosted its stake in shares of Acacia Research by 48.3% during the fourth quarter. Wells Fargo & Company MN now owns 38,898 shares of the business services provider’s stock valued at $145,000 after acquiring an additional 12,675 shares during the last quarter. NewEdge Advisors LLC acquired a new stake in shares of Acacia Research during the fourth quarter valued at $123,000. Finally, Jump Financial LLC purchased a new stake in Acacia Research during the 2nd quarter worth about $101,000. Institutional investors and hedge funds own 86.69% of the company’s stock.

Analyst Upgrades and Downgrades

ACTG has been the topic of several recent research reports. Wall Street Zen upgraded shares of Acacia Research from a “hold” rating to a “buy” rating in a research report on Saturday, November 15th. Weiss Ratings restated a “sell (d)” rating on shares of Acacia Research in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

About Acacia Research

Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.

The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.